Type 3 innate lymphoid cells induce proliferation of CD94+ natural killer cells - 05/10/17
Doi : 10.1016/j.jaci.2017.03.033
Shuo Li, PhD a, b, ∗, Hideaki Morita, MD, PhD a, c, ∗, Beate Rückert, Sci Tec a, c, Tadech Boonpiyathad, MD a, c, Avidan Neumann, PhD a, c, d, Cezmi A. Akdis, MD a, c 
a Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland
b Department of Microbiology, Monash University, Melbourne, Victoria, Australia
c Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland
d Institute of Environmental Medicine, UNIKA-T, Helmholtz Center, Munich, Augsburg, Germany
| This study was supported by the Swiss National Science Foundation (grant no. 310030_156823). |
|
| Disclosure of potential conflict of interest: C. A. Akdis serves as a consultant for Actellion, Aventis, Stallergenes, Alergopharms, and Circacia; received grant support from Novartis, PREDICTA: European Commission's Seventh Framework Programme No. 260895 Research on virus-induced exacerbations, Swiss National Science Foundation, MeDALL: European Commission's Seventh Framework Programme No. 261357, Christine Kühne-Center for Allergy Research and Education, and Actellion, Basel. The rest of the authors declare that that they have no relevant conflicts of interest. |
© 2017
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 140 - N° 4
P. 1156 - octobre 2017 Retour au numéro
Article précédent
- Novel PIK3CD mutations affecting N-terminal residues of p110? cause activated PI3K? syndrome (APDS) in humans
- Andrew J. Takeda, Yu Zhang, Gillian L. Dornan, Braden D. Siempelkamp, Meredith L. Jenkins, Helen F. Matthews, Joshua J. McElwee, Weimin Bi, Filiz O. Seeborg, Helen C. Su, John E. Burke, Carrie L. Lucas
- Direct monitoring of basophil degranulation by using avidin-based probes
- Régis Joulia, Claire Mailhol, Salvatore Valitutti, Alain Didier, Eric Espinosa
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?